EJC Paediatric Oncology (Dec 2023)
BCR:ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS IN CHILDREN AND ADOLESCENTS: INCREASED DISEASE BURDEN IN PATIENTS WITH JAK2 MUTATION, UNMET DIAGNOSTIC NEEDS AND OPTIMAL TREATMENT OPTIONS
- Charikleia Kelaidi,
- Kondylia Antoniadi,
- Loizos Petrikkos,
- Vassilios Papadakis,
- Maria Ampatzidou,
- Maria Kourti,
- Vasiliki Tzotzola,
- Aikaterini Bountali,
- Kalliopi Manola,
- Kalliopi Stefanaki,
- Sophia Polychronopoulou
Affiliations
- Charikleia Kelaidi
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Kondylia Antoniadi
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Loizos Petrikkos
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Vassilios Papadakis
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Maria Ampatzidou
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Maria Kourti
- Third Department of Pediatrics, Aristotle University of Thessaloniki, Greece
- Vasiliki Tzotzola
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Aikaterini Bountali
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Kalliopi Manola
- Laboratory of Health Physics, Radiobiology & Cytogenetics, National Centre for Research ''Demokritos'', Athens, Greece
- Kalliopi Stefanaki
- Department of Pathology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Sophia Polychronopoulou
- Department of Pediatric Hematology and Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
- Journal volume & issue
-
Vol. 2
p. 100041
